FDMT
4D Molecular Therapeutics Inc

1,254
Mkt Cap
$417.09M
Volume
529,160.00
52W High
$12.34
52W Low
$2.24
PE Ratio
-1.83
FDMT Fundamentals
Price
$7.19
Prev Close
$7.30
Open
$7.30
50D MA
$10.15
Beta
1.31
Avg. Volume
1.14M
EPS (Annual)
-$2.98
P/B
0.91
Rev/Employee
$163.00
Loading...
Loading...
News
all
press releases
4D Molecular Therapeutics (NASDAQ:FDMT) Insider Scott Bizily Sells 1,635 Shares
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) insider Scott Bizily sold 1,635 shares of the stock in a transaction dated Tuesday, December 16th. The shares were sold at an average...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down - What's Next?
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down - What's Next...
MarketBeat·18d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Down 4.2% - Here's What Happened
4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 4.2% - Should You Sell...
MarketBeat·21d ago
News Placeholder
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eleven analysts that are currently covering the stock...
MarketBeat·21d ago
News Placeholder
Redmile Group LLC Cuts Stake in 4D Molecular Therapeutics, Inc. $FDMT
Redmile Group LLC trimmed its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) by 88.8% during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·26d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 5.3% - Here's Why
4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Down 5.3% - Should You Sell...
MarketBeat·28d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of 4D Molecular Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
4D Molecular Therapeutics, Inc. $FDMT Shares Sold by Decheng Capital LLC
Decheng Capital LLC lowered its holdings in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) by 28.6% during the second quarter, according to its most recent disclosure with the Securities...
MarketBeat·1mo ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 7.4% - Here's What Happened
4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Down 7.4% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Moderate Buy" from Analysts
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are covering the firm, MarketBeat...
MarketBeat·1mo ago
<
1
2
...
>

Latest FDMT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.